Detalhe da pesquisa
1.
The gut-brain axis: Correlation of choroid plexus volume and permeability with inflammatory biomarkers in Crohn's disease.
Neurobiol Dis
; 192: 106416, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38272141
2.
Gut virome-colonising Orthohepadnavirus genus is associated with ulcerative colitis pathogenesis and induces intestinal inflammation in vivo.
Gut
; 72(10): 1838-1847, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36788014
3.
Noninvasive Assessment of Postoperative Disease Recurrence in Crohn's Disease: A Multicenter, Prospective Cohort Study on Behalf of the Italian Group for Inflammatory Bowel Disease.
Clin Gastroenterol Hepatol
; 21(12): 3143-3151, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36521739
4.
Predictive Value of Bowel Ultrasound in Crohn's Disease: A 12-Month Prospective Study.
Clin Gastroenterol Hepatol
; 20(4): e723-e740, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33895360
5.
Reproducibility of the electronic chromoendoscopy PICaSSO score (Paddington International Virtual ChromoendoScopy ScOre) in ulcerative colitis using multiple endoscopic platforms: a prospective multicenter international study (with video).
Gastrointest Endosc
; 96(1): 73-83, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35182574
6.
Incidence and Patterns of COVID-19 Among Inflammatory Bowel Disease Patients From the Nancy and Milan Cohorts.
Clin Gastroenterol Hepatol
; 18(9): 2134-2135, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32360811
7.
Maintaining the Quality Standards of Care for Inflammatory Bowel Disease Patients During the COVID-19 Pandemic.
Clin Gastroenterol Hepatol
; 18(8): 1882-1883, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32304737
8.
Absence of COVID-19 Infection in Patients Accessing IBD Unit at Humanitas, Milan: Implications for Postlockdown Measures.
Am J Gastroenterol
; 115(10): 1719-1721, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32852334
9.
Advanced endoscopic techniques in the assessment of inflammatory bowel disease: new technology, new era.
Gut
; 68(3): 562-572, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30580249
10.
MFSD2A Promotes Endothelial Generation of Inflammation-Resolving Lipid Mediators and Reduces Colitis in Mice.
Gastroenterology
; 153(5): 1363-1377.e6, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28827082
11.
An Unusual Case of Cardiac Involvement in Crohn's Disease.
Gastroenterology
; 161(2): 431-433, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33385425
12.
Intestinal gas and liver steatosis: a casual association? A prospective multicentre assessment.
Liver Int
; 37(1): 141-147, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27375263
13.
Effectiveness of Mesalazine, Thiopurines and Tumour Necrosis Factor Antagonists in Preventing Post-Operative Crohn's Disease Recurrence in a Real-Life Setting.
Digestion
; 96(3): 166-172, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28903094
14.
Discontinuation of Infliximab in Patients With Ulcerative Colitis Is Associated With Increased Risk of Relapse: A Multinational Retrospective Cohort Study.
Clin Gastroenterol Hepatol
; 14(10): 1426-1432.e1, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27317850
15.
Psychological Challenges for Patients With Inflammatory Bowel Disease During the COVID-19 Pandemic.
Psychosom Med
; 83(4): 397-398, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33234778
16.
Perianal disease is associated with psychiatric co-morbidity in Crohn's disease in remission.
Int J Colorectal Dis
; 29(10): 1285-90, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24986138
17.
Positioning risankizumab in the treatment algorithm of moderate-to-severe Crohn's disease.
Immunotherapy
; 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38629330
18.
The learning curve for using intestinal ultrasonography.
Dig Liver Dis
; 2024 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38320914
19.
Ultrasound remission after biologic induction and long-term endoscopic remission in Crohn's disease: a prospective cohort study.
EClinicalMedicine
; 71: 102559, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38549587
20.
Evaluating the pharmacokinetics of upadacitinib for the treatment of moderate-to-severe Crohn's disease.
Expert Opin Drug Metab Toxicol
; : 1-9, 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38712496